Confluent Appoints Sandy Stojkovski and Brian Yoor to its Board of Directors
SCOTTSDALE, Ariz., March 08, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, a leading materials science platform that supports the design,...
Month: March 2024
Ultimovacs ASA: Mandatory notification of trades by primary insider
Oslo, 8 March 2024: CGS Holding AS, a closely related party of Leiv Askvig, a board member and primary insider...
Sonendo Announces Departure of Chief Financial Officer
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (OTCQX: SONX) (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today...
Psyched Wellness Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - March 8, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Ainos Reports Full Year 2023 Financial Results
Strategic pivot towards VELDONA and AI-powered point-of-care testing to continue in 2024Advancing VELDONA drug candidates to Phase III clinical studiesExpanding...
Avenues Recovery Centers in Louisiana Designated as Blue Distinction(R) Centers
Avenues Recovery Center's Two Louisiana Facilities Designated as Blue Distinction® Centers for Substance Use Treatment and RecoveryNEW ORLEANS, LA /...
Sinceri Senior Living Welcomes New Community in Virginia
VANCOUVER, WA / ACCESSWIRE / March 8, 2024 / Sinceri Senior Living, a senior living management company, is pleased to...
What is GRC in Healthcare?
By Charlie Falcone, CEO at Verisys Charlie Falcone Governance, Risk Management, and Compliance (GRC) in healthcare is an integrated approach...
Embarking on a Transformative Journey: Oxygen Announces Temporary Closure of Banking Services to Focus on Health Solutions
PRINCETON, NJ / ACCESSWIRE / March 8, 2024 / Oxygen, a banking platform dedicated to serving the extraordinary, today announces...
Scientific Industries Announces Industry Veteran, John Nicols, as New Board Member and Chairman of Scientific Bioprocessing Inc.
BOHEMIA, NY / ACCESSWIRE / March 8, 2024 / Scientific Industries, Inc. ("SI") (OTCQB:SCND) announced the appointment of John Nicols...
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence – Forecasts to 2028 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)"...
Red Light Holland Commences Experimental Research on Psilocybin Truffles to Develop Process for Commercial Manufacturing of Natural-Source Active Pharmaceutical Ingredient
Toronto, Ontario--(Newsfile Corp. - March 8, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
AARC Announces Apex Award Recipients for 2024-2025
IRVING, TX / ACCESSWIRE / March 8, 2024 / The American Association for Respiratory Care (AARC) established the Apex Recognition...
Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024
WOBURN, MA / ACCESSWIRE / March 8, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of...
Neptune Appoints Interim President and CEO and Interim COO
LAVAL, QC / ACCESSWIRE / March 8, 2024 / Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT), today announced...
Jolt Health Inc., Letter to the Shareholders
Continuing to build upon the Company's research initiative.Jolt is currently seeking several opportunities, adding to its health and wellness portfolio.Strategic...
Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting
- Cerebrospinal fluid (CSF) biomarker results are highly supportive of sabirnetug’s downstream pharmacological effects in the brain in early AD...
KuCoin’s Impactful CSR Initiative: Empowering 2900 Women and Girls Globally
VICTORIA, Seychelles, March 8, 2024 /PRNewswire/ -- On March 8th, the International Women's Day, KuCoin, the leading crypto trading platform, and the...
BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order
VANCOUVER, BC, March 8, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") today announced...